Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Journal of Translational Medicine

Fig. 5

From: Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm

Fig. 5

Patient-specific values of \(ln\left( {a_{pem} } \right)\), as obtained from fitting the mathematical model to the data of each patient in the training set, versus the estimated values of \(ln\left( {a_{pem} } \right)\) by a Leave-One-Out cross-validation (COO CV) of the k-NN algorithm. Each point represents the parameter values of one patient and the reference line satisfies equality between the fitted and regression-derived parameter values (see “Methods” section)

Back to article page